1. Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.
- Author
-
Østergaard, Simon, Schejbel, Lone, Breinholt, Marie Fredslund, Pedersen, Mette Ølgod, Hammer, Troels, Munksgaard, Lars, Nørgaard, Peter, Høgdall, Estrid, Gjerdrum, Lise Mette Rahbek, and Nielsen, Torsten Holm
- Subjects
- *
NUCLEOTIDE sequencing , *SOMATIC mutation , *LYMPHOMAS , *PHENOTYPES , *GENETIC mutation , *WALDENSTROM'S macroglobulinemia - Abstract
Next-generation sequencing (NGS) affords comprehensive insights into the genomic landscape of lymphomas. We examined the mutational pattern in patients with Waldenström macroglobulinemia (WM) or lymphoplasmacytic lymphoma (LPL) as well as the diagnostic and clinical utility of a tailored NGS lymphoma panel. A consecutive series of 45 patients was reviewed and NGS analysis was performed as part of a routine diagnostic setup. The custom designed NGS panel assayed all coding sequences of 59 genes of known clinical significance in lymphoid neoplasms. The most frequently mutated genes were MYD88, CXCR4, BIRC3, CD79B, and ARID1A. Additional somatic mutations were detected in 17 genes with four mutations categorized as pathogenic or likely pathogenic. BIRC3 and TP53 mutations were associated with adverse clinical phenotypes. NGS performance for the MYD88L265P variant was 96% when compared to qPCR. In conclusion, targeted NGS provided important diagnostic and prognostic information in a routine clinical setting. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF